Royal Bank Of Canada Immunity Bio, Inc. Transaction History
Royal Bank Of Canada
- $528 Billion
- Q2 2025
A detailed history of Royal Bank Of Canada transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 1,225,060 shares of IBRX stock, worth $3.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,225,060
Previous 57,073
2046.48%
Holding current value
$3.03 Million
Previous $171,000
1791.23%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding IBRX
# of Institutions
275Shares Held
120MCall Options Held
2.5MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA21.8MShares$53.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$21.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19.2 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$19.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $989M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...